References
- Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretive strategies for lung function tests. Eur Respir J 2005; 26: 948–68
- Roberts SD, Farber MO, Knox KS, Phillips GS, Bhatt NY, Mastronarde JG, Wood KL. FEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. Chest 2006; 130: 200–6
- Culver BH. Interpretation of spirometry: we can do better than the GOLD standard [Editorial]. Respir Care 2006; 51: 719–21
- Pauwels RA, Buist AS, Calverly PM, Jenkins CR, Hurd SS. GOLD Scientific Committee. Globalstrategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease. Am J Respir Crit Care Med 2001; 163: 1256–76
- Celli BR, MacNee W. ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932–46
- Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: 179–87
- Quanjer Ph, and the FEV1%VC Working Group. The GOLD controversy. Available at: www.spirxpert.com/controversies/controversy.html.